ZYVERSA THERAPEUTICS INC (ZVSA)

US98987D3008 - Common Stock

1.25  +0.01 (+0.81%)

After market: 1.25 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
N/AN/AN/AN/AN/AN/A
423.40%
EBITDA
YoY % growth
-11.823M-7.694M
34.92%		-13.823M
-79.66%		-14.41M
-4.25%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-11.833M-7.704M
34.89%		-13.833M
-79.55%		-14.421M
-4.25%		N/A
-15.66%		N/A
-72.14%		N/A
-40.67%		N/A
-36.24%		N/A
-14.07%		N/A
84.51%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A
97.53%		N/A
93.00%		N/A
-217.07%		N/A
-1,091.03%		N/A
-22.39%		N/A
17.15%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-4.61
96.63%		-0.41
90.99%		-0.41
87.67%		-0.26
89.51%		-0.31
93.36%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.692M
-164.16%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -2.43
92.29%		-3.771.3435.61%
Q2 2024
Q2Q % growth		 -3.31 -3.830.5213.46%
Q1 2024
Q2Q % growth		 -4.53 -3.77-0.76-20.03%
Q4 2023
Q2Q % growth		 -136.80 -21.83-114.97-526.72%
Q3 2023
Q2Q % growth		 -31.50 -57.1225.6244.85%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -11.48% -16.71% -16.71%
RevenueN/A N/A N/A N/A